In this study, we conducted a metabolomic analysis to identify specific metabolites altered in response to an inhibitor of the lysosomal calcium channel TRPML1, aiming to enhance the sensitivity of chemoresistant ovarian cancer cells to cisplatin. Here, MCOLN1 is linked to ovarian cancer.